Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: A possible diagnostic tool for lymph node metastasis

Cancer

Volumn 98, Issue 6, 2003, Pages 1217-1222

  Tamura, Masaya ^a   Ohta, Yasuhiko ^a  

^a ISHIKAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Lymph node metastasis; Vascular endothelial growth factor; Vascular endothelial growth factor C

Indexed keywords

VASCULOTROPIN; VASCULOTROPIN C;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CELL INVASION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; VASCULAR TUMOR;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0042418165     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11529     Document Type: Article

References (20)

1. Ohta Y, Nozawa H, Tanaka Y, et al. Increased vascular endothelial growth factor-C and decreased NM23 expression associated with microdissemination in the lymph nodes in stage Inon-small cell lung cancer. J Thorac Cardiovasc Surg. 2000;119:804-813.
2. Niki T, Iba S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res. 2000;6:2431-2439.
3. Kajita T, Ohta Y, Kimura K, et al. The expression of vascular endothelial growth factor-C and its receptors in non-small cell lung cancer. Br J Cancer. 2001;85:255-260.
4. Graham AN, Chan KJ, Pastorino U, Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117:246-251.
5. Tsang GMK, Watson DCT. The practice of cardiothoracic surgeons in the preoperative staging of non-small cell lung cancer. Thorax. 1992;47:3-5.
6. Goldstraw P, Rocmans P, Bali D, et al. Pretreatment minimal staging for non-small cell lung cancer: an update consensus. Lung Cancer. 1994;11:1-4.
7. Tamura M, Ohta Y, Nakamura H, Oda M, Watanabe G. Diagnostic value of plasma vascular endothelial growth factor as a tumor marker in patients with non-small cell lung cancer. Int J Biol Markers. 2002;17:275-279.
8. Kaipainen A, Korhonen J, Mustonen T, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development, Proc Natl Acad Sci U S A. 1995;92:3566-3570.
9. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase. EMBO J. 1996;15:290-298.
10. Tsurusaki T, Kanda S, Sakai H, et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer. 1999;80:309-313.
11. Yoshikawa T, Tsuburaya A, Kobayashi O, et al. Plasma concentrations of VEGF and b FGF in patients with gastric carcinoma. Cancer Lett. 2000;153:7-12.
12. Harish K, Kamal H, Peter WRL, et al. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res. 1998;4:1279-1285.
13. Yamamoto S, Konishi I, Manda M, et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patients survival, and analysis of serum VEGF levels. Br J Cancer. 1997;76:1221-1227.
14. Tamura M, Ohta Y, Kajita T, et al. Plasma VEGF concentration can predict the tumor angiogenic capacity in non-small cell lung cancer. Oncol Rep. 2001;8:1097-1102.
15. Carlens E. Mediastinotomy: a method for inspection and tissue biopsy in the superior mediastinum. Dis Chest. 1959;36:343-347.
16. McNeil TM, Chamberlain JM. Diagnostic anterior mediastinotomy. Ann Thorac Surg. 1966;2:532-539.
17. Hans CS, Markus H, Florin A, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 1997;202:441-446.
18. Johan FV, Sigrid CS, Paul RDL, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer. Chest. 1997;112:1480-1486.
19. Kemp HK, Kelly AM, Yusuf M, et al. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? Ann Thorac Surg. 2002;73:394-402.
20. Ohta Y, Watanabe Y, Murakami S, et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br J Cancer. 1997;76:1041-1045.